Klotho Neurosciences, Inc. (NASDAQ:KLTO – Get Free Report)’s stock price dropped 4.7% on Thursday . The stock traded as low as $0.37 and last traded at $0.40. Approximately 63,797 shares changed hands during mid-day trading, a decline of 96% from the average daily volume of 1,446,947 shares. The stock had previously closed at $0.42.
Klotho Neurosciences Stock Performance
The company’s 50 day simple moving average is $0.45.
About Klotho Neurosciences
Klotho Neurosciences, Inc, a biopharmaceutical company, develops therapies for neurological and age-related disorders, and specialty diagnostics. Its products include cell and gene therapies to mitigate age-related pathologies, such as dementia symptoms, and Alzheimer and neuromuscular diseases; biologics/biosimilars in the treatment of cancer; and melanocortin receptors.
Featured Stories
- Five stocks we like better than Klotho Neurosciences
- Mastering Discipline: Overcoming Emotional Challenges In Trading
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- What is the Euro STOXX 50 Index?
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Most active stocks: Dollar volume vs share volume
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Klotho Neurosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Klotho Neurosciences and related companies with MarketBeat.com's FREE daily email newsletter.
